Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer: Breakthrough Pain”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Not applicableEnded earlyNCT01651910
What this trial is testing

The Cancer Pain and Unmet Needs Study

Who this might be right for
Cancer
University of Surrey 162
Large-scale testing (Phase 3)Ended earlyNCT00125801
What this trial is testing

The Pain Pen for Breakthrough Cancer Pain

Who this might be right for
NeoplasmsPain
Erasmus Medical Center 50
Large-scale testing (Phase 3)Study completedNCT00459277
What this trial is testing

Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids

Who this might be right for
Cancer Pain
Archimedes Development Ltd 73
Not applicableEnded earlyNCT04468490
What this trial is testing

Treatment of Breakthrough Cancer Pain According to European Guidelines

Who this might be right for
Breakthrough Cancer Pain
Aziende Chimiche Riunite Angelini Francesco S.p.A 131
Not applicableStudy completedNCT01946555
What this trial is testing

Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain

Who this might be right for
TumorCancer PainBreakthrough Cancer Pain+1 more
Mario Negri Institute for Pharmacological Research 150
Not applicableLooking for participantsNCT06287788
What this trial is testing

A Mucosal Contouring Method Based on Swallowing-induced Breakthrough Pain for Radiation-induced Oropharyngeal Mucositis

Who this might be right for
Radiation-induced Oropharyngeal MucositisSwallowing-induced Breakthrough Pain
Nanfang Hospital, Southern Medical University 240
Large-scale testing (Phase 3)Study completedNCT00293033
What this trial is testing

Study of BEMA™ Fentanyl in the Treatment of Breakthrough Pain in Cancer Subjects

Who this might be right for
PainCancer
BioDelivery Sciences International 152
Not applicableStudy completedNCT01400854
What this trial is testing

Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability

Who this might be right for
CancerPain
Cephalon 600
Large-scale testing (Phase 3)Study completedNCT00589823
What this trial is testing

Efficacy and Safety Study of Nasalfent for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids

Who this might be right for
Cancers, Pain
Archimedes Development Ltd 135
Testing effectiveness (Phase 2)WithdrawnNCT03809455
What this trial is testing

Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients

Who this might be right for
Breakthrough Pain
UNICANCER
Testing effectiveness (Phase 2)Study completedNCT00020618
What this trial is testing

Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain

Who this might be right for
PainUnspecified Adult Solid Tumor, Protocol Specific
Dana-Farber Cancer Institute
Post-approval studies (Phase 4)Study completedNCT02869321
What this trial is testing

Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional Gastrostomy

Who this might be right for
GastrostomyBreakthrough PainUpper Aerodigestive Tract Neoplasms
Central Hospital, Nancy, France 20
Testing effectiveness (Phase 2)Study completedNCT00236041
What this trial is testing

Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)

Who this might be right for
CancerBreakthrough Pain
Cephalon 38
Not applicableStudy completedNCT05209906
What this trial is testing

An Observation Study to Assess the Efficacy and Safety of Proportional Doses of Painkyl® in Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer Pain
Mackay Memorial Hospital 37
Testing effectiveness (Phase 2)Study completedNCT05037539
What this trial is testing

Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain

Who this might be right for
Pain, Breakthrough
Department of Medical Services Ministry of Public Health of Thailand 20
Testing effectiveness (Phase 2)Ended earlyNCT00351637
What this trial is testing

Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients

Who this might be right for
CancerPain
Alberta Health services 60
Post-approval studies (Phase 4)Ended earlyNCT00842829
What this trial is testing

Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients

Who this might be right for
Cancer PainBreakthrough Pain
Cephalon 330
Large-scale testing (Phase 3)Study completedNCT00696137
What this trial is testing

Long-term Extension Study of BEMA™ Fentanyl

Who this might be right for
Respiratory Depression
BioDelivery Sciences International 5
Testing effectiveness (Phase 2)Study completedNCT00833040
What this trial is testing

The Evaluation of the Safety, Tolerability, and Efficacy of ARX-F02 (Sufentanil NanoTab) Compared to Placebo in the Treatment of Cancer Breakthrough Pain

Who this might be right for
CancerPain
Talphera, Inc 34
Not applicableStudy completedNCT02050503
What this trial is testing

Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal Mucositis

Who this might be right for
Breakthrough PainMucositisRadiotherapy+2 more
Grupo de Investigación Clínica en Oncología Radioterapia 33
Next Page